Using the Patient Concerns Inventory in the identification of fatigue following treatment for head and neck cancer

Simon Rogers, Cherith Semple, Gerry Humphris, Derek Lowe, Anastasios Kanatas

Research output: Contribution to journalArticlepeer-review

Abstract

Fatigue has a profound impact on health-related quality of life (HRQOL) and the aim of this study is to describe the clinical characteristics and HRQOL for head and neck cancer patients who raise the issue of fatigue on the Patient Concerns Inventory (PCI),at their review consultation. Eight consultants were randomised to use the PCI as part of a cluster-controlled trial. Patients also completed the UW-QoLv4 (University ofWashington Quality of Life), EQ-5D-5L (EuroQol Group) and Distress Thermometer.There were 140 patients who attended clinics at a median (IQR) of 108 (70-165) days after the end of treatment. The PCI item ‘fatigue’ was the 6th most commonly selected, by 29% (40). Those with advanced tumours were more likely (36% 30/83 Vs 18%10/56, p=0.02) to have selected the item, as were those treated with radiotherapy +/-chemotherapy (39% 34/87 Vs 11% 6/53, p<0.001). The PCI fatigue group reported significantly worse overall QOL, social-emotional and physical function composites cores, distress thermometer, and EQ-5D. PCI-fatigue was common in those with sleeping, nausea, mood, depression, mobility, breathing and energy level concerns. In conclusion, given the problems associated with fatigue, it is appropriate to screen and seek interventions that might help patient address this.
Original languageEnglish
Pages (from-to)865-872
Number of pages8
JournalInternational Journal of Oral and Maxillofacial Surgery
Volume50
Issue number7
Early online date26 Nov 2020
DOIs
Publication statusPublished - 1 Jul 2021

Keywords

  • fatigue
  • head and neck neoplasms
  • needs assessment
  • quality of life
  • surveys and questionnaires

Fingerprint

Dive into the research topics of 'Using the Patient Concerns Inventory in the identification of fatigue following treatment for head and neck cancer'. Together they form a unique fingerprint.

Cite this